Lumithera

Developer of photobiomodulation treatments for ocular diseases

placePoulsbo, Washington, United States calendar_todayFounded 2013 groups18 employees language lumithera.com

Registered entities

Innovation

4 patent families (2 granted) — focus: Human necessities; filing pace steady. Cited 1,040 times.

YearFilings
20162
20171
20181
20192
20201
20213
20221
20231
20241
20252
20262

Social engagement

Social engagement: 3.5K social following, 3 posts in the last 12 months — below the industry typical range.

Investor mix

14 investors on record; lead investors include Pengshi Private Equity, WaterStone Capital.

Investor typeCountShare
Venture capital536%
Private equity321%
Angel & family office17%
Other / undisclosed536%

Recent activity

27 Aug 2025
Event
Valeda Symposium
Coming soon